FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/07/092121 [Registered on: 31/07/2025] Trial Registered Prospectively
Last Modified On: 31/07/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Unani 
Study Design  Single Arm Study 
Public Title of Study   Studying the Effect of a Herbal Syrup (Sharbat Ustukhuddus) on Long-Term Sinus Problems 
Scientific Title of Study   To Evaluate the Efficacy of Sharbat-e-Ustukhuddus in the management of Waram Tajawif al-Anf Muzmin (Chronic Rhinosinusitis): An open label interventional clinical study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Mohd Salman 
Designation  PG Scholar 
Affiliation  State Unani Medical College Himmatganj Prayagraj Uttar Pradesh Pin Code 211016 
Address  Department of Amraz-e- Ain Uzn Anf Halaq wa Asnan State Unani Medical College Himmatganj Prayagraj Uttar Pradesh Pin Code 211016

Allahabad
UTTAR PRADESH
211016
India 
Phone  9457801887  
Fax    
Email  msalmanmintorian@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Mohd Asif Hussain Usmani 
Designation  Professor 
Affiliation  State Unani Medical College Himmatganj Prayagraj Uttar Pradesh Pin Code 211016 
Address  Department of Amraz-e- Ain Uzn Anf Halaq wa Asnan State Unani Medical College Himmatganj Prayagraj Uttar Pradesh Pin Code 211016

Allahabad
UTTAR PRADESH
211016
India 
Phone  7905831926  
Fax    
Email  asifhussainusmani@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Mohd Salman 
Designation  PG Scholar 
Affiliation  State Unani Medical College Himmatganj Prayagraj Uttar Pradesh Pin Code 211016 
Address  Department of Amraz-e- Ain Uzn Anf Halaq wa Asnan State Unani Medical College Himmatganj Prayagraj Uttar Pradesh Pin Code 211016

Allahabad
UTTAR PRADESH
211016
India 
Phone  9457801887  
Fax    
Email  msalmanmintorian@gmail.com  
 
Source of Monetary or Material Support  
State Unani Medical College Himmatganj Prayagraj Uttar Pradesh Pin Code 211016 
 
Primary Sponsor  
Name  State Unani Medical College and HAHRDM Hospital Himmatganj Prayagraj 
Address  State Unani Medical College and HAHRDM Hospital Himmatganj Prayagraj Uttar Pradesh Pin Code 211016 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Mohd Salman  State Unani Medical College and HAHRDM Hospital  Department of Amraz-e- Ain Uzn Anf Halaq wa Asnan State Unani Medical College Himmatganj Prayagraj Uttar Pradesh Pin Code 211016
Allahabad
UTTAR PRADESH 
09457801887

msalmanmintorian@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee (IEC) for Biomedical Research  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: J329||Chronic sinusitis, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Not Applicable  Not Applicable 
Intervention  Sharbat Ustukhuddus  Patients will be given Sharbat Ustukhuddus 20 ml twice a day for 6 weeks. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  1 Mild to Moderate case of Chronic Rhinosinusitis
2 Duration of the disease More Than 12 weeks
3 Patient having at least two out of four cardinal symptom (facial pain/pressure, hyposmia or anosmia, nasal obstruction, and nasal discharge for at least 12 consecutive weeks
4 Patient having any of the following symptoms like rhinorrhea, nasal congestion, frontal headache, nasal itching, impaired sense of smell and frequent sneezing for more than 12 weeks
5 X-ray PNS with Positive finding (Thickened mucosal lining, opacity of sinus) 
 
ExclusionCriteria 
Details  1 Patient aged less than 18years or more than 50years.

2 Patient with deviated nasal septum (DNS).

3 Local pathology such as mucocele, cyst, Antrochoanal polyp, facial trauma.

4 Diabetes mellitus and any other illness requiring long term treatment.

5 Pregnant or Lactating Women.

6 Significant Pulmonary or Cardiovascular or Hepatorenal Dysfunction.

7 Patient not willing to attend regular treatment and follow-up for the entire duration of study.

8 Patient having history of any surgery of nose or paranasal sinuses.

9 Patient having history of trauma to nose or sinus area.

10 Patient of pulmonary Koch’s or having history of epistaxis.

11 Any medical condition where physician feels that participation in the study could be detrimental to patient’s wellbeing. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Visual Analog Scale(VAS)
SNOT-22:CRSspecificQoL 
2nd, 4th, and 6th Week from baseline. 
 
Secondary Outcome  
Outcome  TimePoints 
X-RAY (PNS)- Water’s View
AEC(Absolute Eosinophil Count) 
2nd, 4th, and 6th Week from baseline. 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   11/08/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Chronic Rhinosinusitis) is defined as a group of disorders characterized by inflammation of paranasal mucosa and it is due to various aetiologies. Since inflammation of sinuses nearly always involves the nasal mucosa. Rhinosinusitis is now generally preferred term for this condition. Rhinosinusitis is a significant health problem which seems to the mirror the increasing frequency of allergic rhinitis and is an umbrella covering multiple disease entities, including acute Sinusitis, chronic Sinusitis with nasal polyps and chronic Sinusitis without polyps.
Chronic Rhinosinusitis affects approximately 15% of the general population .The National Institute of Allergy and Infectious Diseases (NIAID) estimates 134 million Indians suffer from Chronic rhinosinusitis. Among Indians the disease is more widespread than diabetes, asthma or coronary artery disease. which results in a large financial burden on society. It is one of the most common reason for an individual seeking medical care.
Medical management of Chronic Rhinosinusitis often require combining multiple medications including antibiotics, nasal decongestant, topical nasal steroid or oral steroids and saline irrigation.
There are several single as well as compound Unani drugs which are in use for centuries for effectively treating Chronic Rhinosinusitis but many of them have not been evaluated clinically on scientific parameters further, the limitations of management of Chronic Rhinosinusitis available in modern medicine necessitate a scientific search for safe, effective and convenient medications for the disease.
Keeping this in view, the present study is designed to evaluate the efficacy of Sharbat Ustukhuddus in case of Chronic Rhinosinusitis.

 
Close